ロード中...
Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer
The tryptophan catabolic enzyme indoleamine 2,3-dioxygenase-1 (IDO1) has attracted enormous attention in driving cancer immunosuppression, neovascularization and metastasis. IDO1 suppresses local CD8+ T effector cells and natural killer cells and induces CD4+ T regulatory cells (iTreg) and myeloid-d...
保存先:
| 出版年: | Int Rev Cell Mol Biol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6054468/ https://ncbi.nlm.nih.gov/pubmed/29413890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/bs.ircmb.2017.07.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|